Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122544) titled 'Prospective, Multicenter, Single-Arm Clinical Study of Eculizumab Combined with CD20-Targeted Antibody in the Treatment of Active Proliferative Lupus Nephritis' on April 15.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Zhejiang University School of Medicine

Condition: Lupus Nephritis

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-04-15

Target Sample Size: Experimental group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=306374

Published by HT Digital Con...